IMVAMUNE

This brand name is authorized in Canada

Active ingredients

The drug IMVAMUNE contains one active pharmaceutical ingredient (API):

1 Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN)
UNII JDS6958QAG - VACCINIA VIRUS

Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.

Read about Smallpox, live attenuated

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
IMVAMUNE Suspension for injection Health Products and Food Branch (CA) MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BX Other viral vaccines J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines
Discover more medicines within J07BX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02416638

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.